MYM Nutraceuticals Inc. (CSE:MYM) (OTC: MYMMF ) , is pleased to announce today that it has been made eligible for DTC electronic settlement and transfer of its common shares in the United States under the OTC symbol MYMMF. This approval opens MYM up to the most important and influential investment market on the planet. Current …
MYM Nutraceuticals Inc. (CSE:MYM) (OTC: MYMMF ) , is pleased to announce today that it has been made eligible for DTC electronic settlement and transfer of its common shares in the United States under the OTC symbol MYMMF.
This approval opens MYM up to the most important and influential investment market on the planet. Current US law has prevented American cannabis companies from going public, making it very difficult for Americans to invest in the rapidly expanding multi-billion-dollar cannabis industry. Due to its progressive cannabis laws, Canada has become the Mecca for cannabis investment worldwide. MYM not only has a foothold in Canada but is expanding into the US and internationally to build a global brand.
“We are very pleased to be trading on the US market as it will provide our American investors with timely news and information to help them better analyze, value and trade our securities,” said Rob Gietl, CEO of MYM. “Without a US symbol it is difficult for Americans to buy shares in a Canadian company. This removes that barrier, and is very timely for MYM as we are currently in talks with several US companies in the cannabis space.”
MYM shares trade in Canada, Germany and the USA under the following symbols: (CSE: MYM) (OTC:MYMMF) (FRA:0MY) (DEU:0MY) (MUN:0MY) (STU:0MY)
MYM is continuing to negotiate acquisitions of complimentary businesses and assets in the technology, nutraceuticals and CBD sector, and is currently in talks with other innovative companies to ensure a strong presence and growth potential within the industry.
MYM Nutraceuticals Inc. (CSE:MYM)(OTC:MYMMF)(FRA:OMY) is a public company trading on the Canadian Stock Exchange whose primary focus is developing high-end organic medicinal cannabis supplements and topical products. MYM also has an interest in the development of high-density farming facilities and technologies that allow MYM to expand its brand into the global market.
ON BEHALF OF THE BOARD
“ Rob Gietl”
Rob Gietl, CEO
MYM Nutraceuticals Inc.
This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.
This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE), accepts responsibility for the adequacy or accuracy of this release.
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities law and may not be offered or sold in the “United States”, as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.